Package 60505-2850-9

Brand: alfuzosin hydrochloride

Generic: alfuzosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 60505-2850-9
Digits Only 6050528509
Product NDC 60505-2850
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9)

Marketing

Marketing Status
Marketed Since 2023-09-08
Brand alfuzosin hydrochloride
Generic alfuzosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5632aa3d-c35f-10fe-3ad1-7d1632a1c1c8", "openfda": {"unii": ["75046A1XTN"], "rxcui": ["861132"], "spl_set_id": ["26fcc267-c8d7-e059-1bcf-830dded43690"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-2850-9)", "package_ndc": "60505-2850-9", "marketing_start_date": "20230908"}], "brand_name": "Alfuzosin Hydrochloride", "product_id": "60505-2850_5632aa3d-c35f-10fe-3ad1-7d1632a1c1c8", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "60505-2850", "generic_name": "Alfuzosin Hydrochloride", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alfuzosin Hydrochloride", "active_ingredients": [{"name": "ALFUZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA079013", "marketing_category": "ANDA", "marketing_start_date": "20230908", "listing_expiration_date": "20261231"}